Merck(MRK) - 2025 Q1 - Quarterly Report

Washington, D.C. 20549 UNITED STATES FORM 10-Q SECURITIES AND EXCHANGE COMMISSION ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Rahway New Jersey 07065 (Address of principal executive offices) (zip code) (Registrant's telephone number, including area code) (732) 594-4000 For the transition period from ______ to ______ Commissi ...